RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 MANTRA-PAF
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 28 suppl 2
SP 8
OP 9
DO 10.1177/1559897715612460
UL http://mdc.sagepub.com/content/15/28_suppl_2/8.abstract
AB At 5 years, patients in the MANTRA-PAF trial treated with radiofrequency ablation had less atrial fibrillation burden and episodes of symptomatic atrial fibrillation compared with antiarrhythmic drug. However, there was no significant difference in quality of life measures.